The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Mar. 28, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven
